240 related articles for article (PubMed ID: 9797874)
1. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
[TBL] [Abstract][Full Text] [Related]
2. [Construction and application of retroviral vector carrying green fluorescent protein].
Wang H; Qian Q; Cao H; Wei L; Qu Z; Da W; Guo Y; Wu M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Aug; 15(4):232-4. PubMed ID: 9691133
[TBL] [Abstract][Full Text] [Related]
3. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
[TBL] [Abstract][Full Text] [Related]
4. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
[TBL] [Abstract][Full Text] [Related]
5. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
Byun J; Kim JM; Robbins PD; Kim S
Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
[TBL] [Abstract][Full Text] [Related]
6. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
8. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
9. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein.
Aran JM; Gottesman MM; Pastan I
Cancer Gene Ther; 1998; 5(4):195-206. PubMed ID: 9694071
[TBL] [Abstract][Full Text] [Related]
11. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
[TBL] [Abstract][Full Text] [Related]
12. Reliable generation of stable high titer producer cell lines for gene therapy.
Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M
Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM
Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311
[TBL] [Abstract][Full Text] [Related]
14. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.
Staal FJ; Bakker AQ; Verkuijlen M; van Oort E; Spits H
Cancer Gene Ther; 1996; 3(5):345-51. PubMed ID: 8894254
[TBL] [Abstract][Full Text] [Related]
15. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous flow cytometric analyses of enhanced green and yellow fluorescent proteins and cell surface antigens in doubly transduced immature hematopoietic cell populations.
Stull RA; Hyun WC; Pallavicini MG
Cytometry; 2000 Jun; 40(2):126-34. PubMed ID: 10805932
[TBL] [Abstract][Full Text] [Related]
17. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ
J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836
[TBL] [Abstract][Full Text] [Related]
18. Removal of selectable marker gene from fibroblast cells in transgenic cloned cattle by transient expression of Cre recombinase and subsequent effects on recloned embryo development.
Wang S; Sun X; Ding F; Zhang K; Zhao R; Li S; Li R; Tang B; Zhang L; Liu Y; Li J; Gao F; Wang H; Wang L; Dai Y; Li N
Theriogenology; 2009 Sep; 72(4):535-41. PubMed ID: 19515406
[TBL] [Abstract][Full Text] [Related]
19. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
Hanazono Y; Yu JM; Dunbar CE; Emmons RV
Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126
[TBL] [Abstract][Full Text] [Related]
20. Sorting vector producer cells for high transgene expression increases retroviral titer.
Beaudoin EL; Bais AJ; Junghans RP
J Virol Methods; 2008 Mar; 148(1-2):253-9. PubMed ID: 18249448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
